Cargando…
Fertility drugs, reproductive strategies and ovarian cancer risk
Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treate...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020377/ https://www.ncbi.nlm.nih.gov/pubmed/24829615 http://dx.doi.org/10.1186/1757-2215-7-51 |
_version_ | 1782316058779058176 |
---|---|
author | Tomao, Federica Lo Russo, Giuseppe Spinelli, Gian Paolo Stati, Valeria Prete, Alessandra Anna Prinzi, Natalie Sinjari, Marsela Vici, Patrizia Papa, Anselmo Chiotti, Maria Stefania Benedetti Panici, Pierluigi Tomao, Silverio |
author_facet | Tomao, Federica Lo Russo, Giuseppe Spinelli, Gian Paolo Stati, Valeria Prete, Alessandra Anna Prinzi, Natalie Sinjari, Marsela Vici, Patrizia Papa, Anselmo Chiotti, Maria Stefania Benedetti Panici, Pierluigi Tomao, Silverio |
author_sort | Tomao, Federica |
collection | PubMed |
description | Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treated for infertility is very complex, mainly because of many factors that can contribute to occurrence of cancer in these patients (including parity status). This article addresses the possible association between the use of fertility treatments and the risk of ovarian cancer, through a scrupulous search of the literature published thus far in this field. Our principal objective was to give more conclusive answers on the question whether the use of fertility drug significantly increases ovarian cancer risk. Our analysis focused on the different types of drugs and different treatment schedules used. This study provides additional insights regarding the long-term relationships between fertility drugs and risk of ovarian cancer. |
format | Online Article Text |
id | pubmed-4020377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40203772014-05-15 Fertility drugs, reproductive strategies and ovarian cancer risk Tomao, Federica Lo Russo, Giuseppe Spinelli, Gian Paolo Stati, Valeria Prete, Alessandra Anna Prinzi, Natalie Sinjari, Marsela Vici, Patrizia Papa, Anselmo Chiotti, Maria Stefania Benedetti Panici, Pierluigi Tomao, Silverio J Ovarian Res Review Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treated for infertility is very complex, mainly because of many factors that can contribute to occurrence of cancer in these patients (including parity status). This article addresses the possible association between the use of fertility treatments and the risk of ovarian cancer, through a scrupulous search of the literature published thus far in this field. Our principal objective was to give more conclusive answers on the question whether the use of fertility drug significantly increases ovarian cancer risk. Our analysis focused on the different types of drugs and different treatment schedules used. This study provides additional insights regarding the long-term relationships between fertility drugs and risk of ovarian cancer. BioMed Central 2014-05-08 /pmc/articles/PMC4020377/ /pubmed/24829615 http://dx.doi.org/10.1186/1757-2215-7-51 Text en Copyright © 2014 Tomao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Tomao, Federica Lo Russo, Giuseppe Spinelli, Gian Paolo Stati, Valeria Prete, Alessandra Anna Prinzi, Natalie Sinjari, Marsela Vici, Patrizia Papa, Anselmo Chiotti, Maria Stefania Benedetti Panici, Pierluigi Tomao, Silverio Fertility drugs, reproductive strategies and ovarian cancer risk |
title | Fertility drugs, reproductive strategies and ovarian cancer risk |
title_full | Fertility drugs, reproductive strategies and ovarian cancer risk |
title_fullStr | Fertility drugs, reproductive strategies and ovarian cancer risk |
title_full_unstemmed | Fertility drugs, reproductive strategies and ovarian cancer risk |
title_short | Fertility drugs, reproductive strategies and ovarian cancer risk |
title_sort | fertility drugs, reproductive strategies and ovarian cancer risk |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020377/ https://www.ncbi.nlm.nih.gov/pubmed/24829615 http://dx.doi.org/10.1186/1757-2215-7-51 |
work_keys_str_mv | AT tomaofederica fertilitydrugsreproductivestrategiesandovariancancerrisk AT lorussogiuseppe fertilitydrugsreproductivestrategiesandovariancancerrisk AT spinelligianpaolo fertilitydrugsreproductivestrategiesandovariancancerrisk AT stativaleria fertilitydrugsreproductivestrategiesandovariancancerrisk AT pretealessandraanna fertilitydrugsreproductivestrategiesandovariancancerrisk AT prinzinatalie fertilitydrugsreproductivestrategiesandovariancancerrisk AT sinjarimarsela fertilitydrugsreproductivestrategiesandovariancancerrisk AT vicipatrizia fertilitydrugsreproductivestrategiesandovariancancerrisk AT papaanselmo fertilitydrugsreproductivestrategiesandovariancancerrisk AT chiottimariastefania fertilitydrugsreproductivestrategiesandovariancancerrisk AT benedettipanicipierluigi fertilitydrugsreproductivestrategiesandovariancancerrisk AT tomaosilverio fertilitydrugsreproductivestrategiesandovariancancerrisk |